These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29987817)

  • 1. Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
    Turnbull IC; Mayourian J; Murphy JF; Stillitano F; Ceholski DK; Costa KD
    Methods Mol Biol; 2018; 1816():145-159. PubMed ID: 29987817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue.
    Lock RI; Graney PL; Tavakol DN; Nash TR; Kim Y; Sanchez E; Morsink M; Ning D; Chen C; Fleischer S; Baldassarri I; Vunjak-Novakovic G
    Cell Rep; 2024 Jun; 43(6):114302. PubMed ID: 38824644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.
    Cashman TJ; Josowitz R; Johnson BV; Gelb BD; Costa KD
    PLoS One; 2016; 11(1):e0146697. PubMed ID: 26784941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues.
    Murphy JF; Mayourian J; Stillitano F; Munawar S; Broughton KM; Agullo-Pascual E; Sussman MA; Hajjar RJ; Costa KD; Turnbull IC
    Stem Cell Res Ther; 2019 Dec; 10(1):373. PubMed ID: 31801634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.
    Feyen DAM; McKeithan WL; Bruyneel AAN; Spiering S; Hörmann L; Ulmer B; Zhang H; Briganti F; Schweizer M; Hegyi B; Liao Z; Pölönen RP; Ginsburg KS; Lam CK; Serrano R; Wahlquist C; Kreymerman A; Vu M; Amatya PL; Behrens CS; Ranjbarvaziri S; Maas RGC; Greenhaw M; Bernstein D; Wu JC; Bers DM; Eschenhagen T; Metallo CM; Mercola M
    Cell Rep; 2020 Jul; 32(3):107925. PubMed ID: 32697997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.
    Feyen DAM; Perea-Gil I; Maas RGC; Harakalova M; Gavidia AA; Arthur Ataam J; Wu TH; Vink A; Pei J; Vadgama N; Suurmeijer AJ; Te Rijdt WP; Vu M; Amatya PL; Prado M; Zhang Y; Dunkenberger L; Sluijter JPG; Sallam K; Asselbergs FW; Mercola M; Karakikes I
    Circulation; 2021 Aug; 144(5):382-392. PubMed ID: 33928785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
    Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
    J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue.
    Serpooshan V; Chen P; Wu H; Lee S; Sharma A; Hu DA; Venkatraman S; Ganesan AV; Usta OB; Yarmush M; Yang F; Wu JC; Demirci U; Wu SM
    Biomaterials; 2017 Jul; 131():47-57. PubMed ID: 28376365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues.
    van Neste CC; Wiley KA; Chang SW; Borrello J; Turnbull IC; Costa KD
    J Vis Exp; 2023 Jun; (196):. PubMed ID: 37335101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch.
    Wheelwright M; Mikkila J; Bedada FB; Mandegar MA; Thompson BR; Metzger JM
    Stem Cells; 2020 Oct; 38(10):1254-1266. PubMed ID: 32497296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium.
    Lu K; Seidel T; Cao-Ehlker X; Dorn T; Batcha AMN; Schneider CM; Semmler M; Volk T; Moretti A; Dendorfer A; Tomasi R
    Theranostics; 2021; 11(13):6138-6153. PubMed ID: 33995650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility.
    Blazeski A; Zhu R; Hunter DW; Weinberg SH; Zambidis ET; Tung L
    Prog Biophys Mol Biol; 2012; 110(2-3):166-77. PubMed ID: 22971665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Method for Contraction Force Measurement of hiPSC-Derived Engineered Cardiac Tissues.
    Fujiwara Y; Deguchi K; Miki K; Nishimoto T; Yoshida Y
    Methods Mol Biol; 2021; 2320():171-180. PubMed ID: 34302658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro.
    Kensah G; Roa Lara A; Dahlmann J; Zweigerdt R; Schwanke K; Hegermann J; Skvorc D; Gawol A; Azizian A; Wagner S; Maier LS; Krause A; Dräger G; Ochs M; Haverich A; Gruh I; Martin U
    Eur Heart J; 2013 Apr; 34(15):1134-46. PubMed ID: 23103664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
    Feric NT; Radisic M
    Adv Drug Deliv Rev; 2016 Jan; 96():110-34. PubMed ID: 25956564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.